Latest

TAC intervention leads to important legal advance: public interest concerns are relevant in determining interim interdict in patent cases

        On 26 July 2012, the Supreme Court of Appeal handed down its judgment in the matter between the Aventis group of pharmaceutical companies and Cipla’s group of generic pharmaceutical companies. This is the first judgment to decisively say that public interest considerations must be taken into account when balancing the interests […]

READ MORE

International patent laws fail the poor: UN commission

An important  United Nations commission has made a number of recommendations for law reform relating to intellectual property and access to medicines. Notably, the commission recognises that the current international patent regime does not serve the interests of the poor. The report, entitled “HIV and the Law: Risks, Rights & Health” was published this month […]

READ MORE

WHY DOES A COURT CASE IN INDIA MATTER FOR SOUTH AFRICA?

By Mara Kardas-Nelson, Access & Innovation Officer, MSF South Africa The Indian government is being taken to court. After the country’s patent office rejected a patent application filed for imatinib mesylate, branded Gleevec or Glivec, the drug company Novartis filed for legal action against the government of India over the country’s strict patentability criteria as […]

READ MORE

Join our march in support of India, against Novartis

TODAY at 13:00 South African health activists, academics, medical doctors, government representatives, and lawyers will gather in Cape Town to rally against the legal case by the drug company Novartis against the government of India. The outcome of the case will have far-reaching impacts and activists from India and South Africa speaking at the rally […]

READ MORE

Invitation to attend TAC and MSF workshop during the Peoples Health Assembly

When: 14:30 – 16:30, Sunday 8 July 2012 Where: Peoples Health Assembly, The University of the Western Cape (UWC), Room TBA Attendance open to all registered participants of the PHA During the 3rd Peoples Health Assembly, to be hosted in Cape Town from 6 – 11 July, the Treatment Action Campaign and Médecins Sans Frontières […]

READ MORE

Law professor at UKZN demonstrates how SA’s patent laws favour foreign companies

In 2011 Professor Yousuf Vawda of the Law Faculty at the University of Kwazulu-Natal wrote an important paper titled ‘Pharmaceutical Innovation, Incremental Patenting and Compulsory Licensing Country Case Study: South Africa’. This report was commissioned by the International Development Research Centre (IDRC) on the same topic in five developing countries (Argentina, Brazil, Colombia, India and […]

READ MORE

Invitation to a public lecture at UCT: FIX THE LAW, SAVE OUR LIVES

  A public lecture by Catherine Tomlinson, Senior Researcher for the Treatment Action Campaign and Mara Kardas-Nelson, Access and Innovation Officer for Médecins Sans Frontières   When: 14 June 2012, 18:00 for 18:30        Where: Barnard Fuller, Conference Room 4, University of Cape Town On Thursday, 14 June 2012 the Peoples Health Movement, the Treatment Action […]

READ MORE